Several biotechnology companies have recently earned ratings from analysts as of April 28, 2026. These ratings are often driven by positive clinical trial progress, strategic acquisitions, or analyst upgrades following strong performance. Latest Analyst "Strong Buy" Upgrades
: Upgraded to Strong Buy by Truist Financial and BTIG Research . strong buy biotech stocks
Analysts have also highlighted smaller or more specialized innovators with high upside potential: Biotechnology - Yahoo Finance strong buy biotech stocks
: Rating increased to Strong Buy at Truist Financial. strong buy biotech stocks